Adenosinergic modulation of respiratory activity: developmental plasticity induced by perinatal caffeine administration.

@article{Montandon2008AdenosinergicMO,
  title={Adenosinergic modulation of respiratory activity: developmental plasticity induced by perinatal caffeine administration.},
  author={Gaspard Montandon and Richard Kinkead and Aida Bairam},
  journal={Respiratory physiology & neurobiology},
  year={2008},
  volume={164 1-2},
  pages={87-95}
}
Caffeine is an adenosine receptor antagonist that is commonly used in the clinic as a respiratory stimulant to treat apnea of prematurity. A recent clinical study showed that newborns treated with caffeine present no neuro-developmental disabilities at 2 years of age in comparison to placebo-treated children [Schmidt, B., Roberts, R.S., Davis, P., Doyle, L.W., Barrington, K.J., Ohlsson, A., Solimano, A., Tin, W., 2007. Long-term effects of caffeine therapy for apnea of prematurity. N. Engl. J… CONTINUE READING